274 related articles for article (PubMed ID: 28424619)
1. Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An
Romano GL; Platania CBM; Drago F; Salomone S; Ragusa M; Barbagallo C; Di Pietro C; Purrello M; Reibaldi M; Avitabile T; Longo A; Bucolo C
Front Pharmacol; 2017; 8():168. PubMed ID: 28424619
[TBL] [Abstract][Full Text] [Related]
2. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
Pogue AI; Lukiw WJ
Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA target prediction in glaucoma.
Romano GL; Platania CB; Forte S; Salomone S; Drago F; Bucolo C
Prog Brain Res; 2015; 220():217-40. PubMed ID: 26497793
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNAs as Potential Biomarkers of Age-Related Macular Degeneration.
Ren C; Liu Q; Wei Q; Cai W; He M; Du Y; Xu D; Wu Y; Yu J
Cell Physiol Biochem; 2017; 41(4):1413-1423. PubMed ID: 28315863
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Expression Patterns Involved in Amyloid Beta-Induced Retinal Degeneration.
Huang P; Sun J; Wang F; Luo X; Feng J; Gu Q; Liu T; Sun X
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1726-1735. PubMed ID: 28324113
[TBL] [Abstract][Full Text] [Related]
6. miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD).
SanGiovanni JP; SanGiovanni PM; Sapieha P; De Guire V
Clin Chem Lab Med; 2017 May; 55(5):763-775. PubMed ID: 28343170
[TBL] [Abstract][Full Text] [Related]
7. An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology.
Berber P; Grassmann F; Kiel C; Weber BH
Mol Diagn Ther; 2017 Feb; 21(1):31-43. PubMed ID: 27658786
[TBL] [Abstract][Full Text] [Related]
8. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).
Lukiw WJ; Surjyadipta B; Dua P; Alexandrov PN
Int J Biochem Mol Biol; 2012; 3(1):105-16. PubMed ID: 22509485
[TBL] [Abstract][Full Text] [Related]
9. The Role of Dysregulated miRNAs in the Pathogenesis, Diagnosis and Treatment of Age-Related Macular Degeneration.
Urbańska K; Stępień PW; Nowakowska KN; Stefaniak M; Osial N; Chorągiewicz T; Toro MD; Nowomiejska K; Rejdak R
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887109
[TBL] [Abstract][Full Text] [Related]
10. Parallel findings in age-related macular degeneration and Alzheimer's disease.
Ohno-Matsui K
Prog Retin Eye Res; 2011 Jul; 30(4):217-38. PubMed ID: 21440663
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Serum MicroRNAs in Age-Related Macular Degeneration.
ElShelmani H; Wride MA; Saad T; Rani S; Kelly DJ; Keegan D
Transl Vis Sci Technol; 2020 Mar; 9(4):28. PubMed ID: 32818115
[TBL] [Abstract][Full Text] [Related]
12. Three new circulating microRNAs may be associated with wet age-related macular degeneration.
Elbay A; Ercan Ç; Akbaş F; Bulut H; Ozdemir H
Scand J Clin Lab Invest; 2019 Oct; 79(6):388-394. PubMed ID: 31277558
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 prevents rat retinal insult induced by amyloid-β (1-42) oligomers.
Fisichella V; Giurdanella G; Platania CB; Romano GL; Leggio GM; Salomone S; Drago F; Caraci F; Bucolo C
Eur J Pharmacol; 2016 Sep; 787():72-7. PubMed ID: 26845696
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD.
Ménard C; Rezende FA; Miloudi K; Wilson A; Tétreault N; Hardy P; SanGiovanni JP; De Guire V; Sapieha P
Oncotarget; 2016 Apr; 7(15):19171-84. PubMed ID: 27015561
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas.
Dentchev T; Milam AH; Lee VM; Trojanowski JQ; Dunaief JL
Mol Vis; 2003 May; 9():184-90. PubMed ID: 12764254
[TBL] [Abstract][Full Text] [Related]
16. The Role of Deregulated MicroRNAs in Age-Related Macular Degeneration Pathology.
ElShelmani H; Wride MA; Saad T; Rani S; Kelly DJ; Keegan D
Transl Vis Sci Technol; 2021 Feb; 10(2):12. PubMed ID: 34003896
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in microRNAs and their binding sites within gene 3'UTRs associate with susceptibility to age-related macular degeneration.
Ghanbari M; Erkeland SJ; Xu L; Colijn JM; Franco OH; Dehghan A; Klaver CCW; Meester-Smoor MA
Hum Mutat; 2017 Jul; 38(7):827-838. PubMed ID: 28397307
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA as Therapeutics for Age-Related Macular Degeneration.
Natoli R; Fernando N
Adv Exp Med Biol; 2018; 1074():37-43. PubMed ID: 29721925
[TBL] [Abstract][Full Text] [Related]
19. miR-25 Mediates Retinal Degeneration Via Inhibiting ITGAV and PEDF in Rat.
Zhang J; Wang J; Zheng L; Wang M; Lu Y; Li Z; Lian C; Mao S; Hou X; Li S; Xu J; Tian H; Jin C; Gao F; Zhang J; Wang F; Li W; Lu L; Xu GT
Curr Mol Med; 2017; 17(5):359-374. PubMed ID: 29210651
[TBL] [Abstract][Full Text] [Related]
20. MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD).
Parsons CG; Ruitenberg M; Freitag CE; Sroka-Saidi K; Russ H; Rammes G
Neuropharmacology; 2015 May; 92():158-69. PubMed ID: 25634238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
